Chemours Widens FY2026 Sales Guidance from $5.982B-$6.098B to $5.866B-$6.098B vs $6.044B Est

Chemours (NYSE:CC) widens FY2026 sales outlook from $5.982 billion-$6.098 billion to $5.866 billion-$6.098 billion vs $6.044 billion estimate.